# Evaluation of the Efficacy of Anthelmintic Drugs Against Trichinella spiralis Larvae

**Authors:** Soon-Ok Lee, Su In Heo, Hyeon-Woo Nam, Ji-Hyun Lee, Ki Back Chu, Gi-Ja Lee, Tong In Oh, Sung Soo Kim, Fu-Shi Quan

PMC · DOI: 10.3390/antibiotics15020215 · Antibiotics · 2026-02-16

## TL;DR

This study evaluates drugs against Trichinella spiralis larvae and finds tribendimidine (TBD) to be more effective than albendazole.

## Contribution

A validated in vitro assay and evidence that TBD is more effective against T. spiralis larvae than current drugs.

## Key findings

- TBD had the lowest IC50 value of 135.2 μM against T. spiralis larvae in vitro.
- TBD reduced larval burdens and histopathological changes in mouse muscles more effectively than ABZ.
- XTT assay effectively quantified larval viability and correlated with larval numbers.

## Abstract

Background: Albendazole, mebendazole, and ivermectin are effective against adult Trichinella spiralis but show limited efficacy against encapsulated muscle stage larvae. This limitation highlights the need for improved experimental approaches to evaluate anthelmintic activity at this stage and to identify alternative therapeutic candidates. Methods: Seven antiparasitic drugs, albendazole (ABZ), miltefosine (MLT), ivermectin (IVM), tribendimidine (TBD), praziquantel (PZQ), artesunate (ART), and mefloquine (MEQ), were evaluated for in vitro activity against T. spiralis muscle larvae. Larval viability was quantified using a tetrazolium salt XTT assay to determine IC50 values and compare with microscopic assessments. Based on in vitro activity, TBD was selected for in vivo evaluation in a mouse model, where efficacy was assessed by muscle larval burden and histopathological changes. Results: TBD, MEQ, IVM, and ABZ exhibited measurable in vitro efficacies against T. spiralis larvae, with TBD showing the lowest IC50 value at 135.2 μM. XTT formazan absorbance correlated strongly with larval number and incubation time. In vivo, TBD treatment significantly reduced larval burdens in diaphragm and gastrocnemius muscles and was associated with reduced collagen capsule thickness, inflammation, and fibrosis compared with ABZ-treated controls. Conclusions: This study validated an assay for quantitative evaluation of T. spiralis muscle larvae and demonstrates robust in vitro and in vivo activity of TBD against this stage.

## Linked entities

- **Chemicals:** albendazole (PubChem CID 2082), miltefosine (PubChem CID 3599), tribendimidine (PubChem CID 3086564), praziquantel (PubChem CID 4891), artesunate (PubChem CID 6917864), mefloquine (PubChem CID 4046)
- **Diseases:** trichinellosis (MONDO:0019444)
- **Species:** Trichinella spiralis (taxon 6334), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), T. spiralis infection (MESH:D007239), death (MESH:D003643), dislocation (MESH:D004204), myalgia (MESH:D063806), Trichinellosis (MESH:D014235), Inflammatory (MESH:D007249), injury to (MESH:D014947), disease (MESH:D004194), Fibrosis (MESH:D005355), fever (MESH:D005334)
- **Chemicals:** TBD (MESH:C056017), MLT (MESH:C039128), PSR (MESH:C009798), hematoxylin (MESH:D006416), penicillin (MESH:D010406), benzimidazoles (MESH:D001562), IVM.TBD (-), H&amp;E (MESH:D006371), DMSO (MESH:D004121), formalin (MESH:D005557), eosin (MESH:D004801), alcohols (MESH:D000438), CO2 (MESH:D002245), ABZ (MESH:D015766), streptomycin (MESH:D013307), xylene (MESH:D014992), Formazan (MESH:D005562), mebendazole (MESH:D008463), IVM (MESH:D007559), paraffin (MESH:D010232), MEQ (MESH:D015767), ART (MESH:D000077332), PZQ (MESH:D011223), Benzimidazole (MESH:C031000), HCl (MESH:D006851), XTT formazan (MESH:C059088), water (MESH:D014867), Tetrazolium salt (MESH:D013778)
- **Species:** Homo sapiens (human, species) [taxon 9606], Trichinella spiralis (species) [taxon 6334], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937466/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937466/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937466/full.md

---
Source: https://tomesphere.com/paper/PMC12937466